Reach Us +441414719275

A Multipurpose Preclinical and Clinical Diagnostic Tool Fatemeh Nouri

Fateme Nouri*

Department of Biochemical Toxicology, US Food and Drug Administration, Jefferson, AR, USA

*Corresponding Author:
Fateme Nouri
Department of Biochemical Toxicology
US Food and Drug Administration
Jefferson, AR, USA
Tel: +1 870 543 7050
E-mail: [email protected]

Received Date: October 18, 2017 Accepted Date: October 20, 2017 Published Date: October 31, 2017

Citation: Nouri F. A Multipurpose Preclinical and Clinical Diagnostic Tool. J Biomed Sci Appl Vol. 1 No. 1:4.

Copyright: © 2017 Nouri F. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Biomedical Science & Applications

Editorial

Dual polarization interferometry (DPI) is an optical biosensor technique that is based on the use of an evanescent light field [1]. It can probe the molecular layers present and/or the molecular interactions taking place on the surface of an optical waveguide. The principles of DPI are based on two polarized light beams that travel through two waveguides (a sensing waveguide and reference waveguide) to create fringe patterns. A protein that is located above the sensing waveguide changes the speed of light, leading to a different interference pattern. These changes are interpreted by an Analight system to give information on surface bound thickness, refractive index, density and mass. These parameters will change as a result of protein-protein or protein-ligand interactions, and their analysis allows various mechanistic stages of the binding process to be discriminated [2]. In compare, the widely used surface plasmon resonance (SPR) technique, utilizes only a single polarization, i.e., transverse magnetic (TM) polarization and can only provide information on the relative changes in the mass of the layer(s) on the sensor surface. On the other hand, nuclear magnetic resonance (NMR), X-ray crystallography, and neutron reflectivity (NR) techniques just provide information about structural changes [3]. The highly sensitive and accurate DPI technique, takes the advantage of measuring both TM and transverse electric (TE) polarizations and not only detect structural changes but also monitor binding events of a non-labelled protein kinetically by real time measuring of changes in thickness, density and, mass. DPI has been applied successfully to the study of a variety of different biomolecular interactions, e.g., protein/protein, protein/ligand and lipid/membrane interactions [4]. Malfunctions in proteins, causing their aggregation, or the way that they interact with other proteins or lipids can lead to specific disease states, and DPI provides a route to investigating some of these key mechanisms. Moreover, DPI as a platform with the capacity for measuring binding interactions and conformational changes can be used to examine biomolecular interactions in a lipid environment.

This method is used as one of the most advanced, accurate and sensitive diagnostic tool in drug discovery, antibody analysis, nanomolecular studies and early stage detection of diseases. DPI can detect the minor structural differences in both transitory and stable structure of prions that influences their pathological properties. DPI distinguishes between different strains of prions as well as between normal and abnormal isoforms and illuminates the characteristics of prion diseases [5]. Recently, the real-time kinetic of Aβ1-42 binding to extracellular domain of β-amyloid receptor LilrB2 is measured by DPI. This revealed that high-molecular weight oligomers of Aβ1-42 have a higher affinity to receptor with a faster receptor association than monomer Aβ1-42 or lowmolecular weight oligomers of Aβ1-42 [6]. In has been shown that the interaction of oligomeric Aβ and LilrB2 stimulates cofilin signaling leading to impaired synaptic plasticity and dementia in Alzheimer's disease [7]. Using this method, the result of a study showed that truncated heptamer penetratin does not efficiently cross the cell membrane and is not a suitable vehicle for bioactive drugs [8]. Penetratin is a 16-mer Cell-penetrating peptide that is derived from the third helix of Drosophila Antennapedia homeodomain (AntpHD). Penetratin can penetrate cellular and nuclear membranes without triggering cellular degradation and is considered as a drug delivery tool [9]. Another study, took the advantage of DPI to determine the inhibitory effect of gossypol on apurinic/ apyrimidinic endonuclease (APE1) that is a DNA repair endonuclease. DPI showed that gossypol directly interact with APE1and inhibit cell proliferation as an anti-cancer compound [10]. Song et al. in 2013 used DPI to determine the affinity of estrogen receptor α (ERα) to estrogen response elements (EREs) in DNA. Mutations in ERE change the binding affinity of ERα to ERE and lead to misregulation of downstream genes. In this study different ERE sequences were immobilized on the chip surface and binding affinity of ERα to these sequences were examined [11]. Upregulation of estrogen signaling pathway promotes breast cell growth and tumor progression. However, downregulation [12] of this pathway is linked to a less frequent form of breast cancer known as triple negative breast cancer.

In conclusion, a developed DPI method can be used in early diagnosis and monitoring of cancer as a sensitive and harmless technique by detecting low concentration biomarkers. A DPI biosensor that is linked to capture probes of DNA, oligonucleotides complementary to miRNAs or antibodies against proteins of interest can detect very low abundant biomarkers of interest.

References

 

Select your language of interest to view the total content in your interested language

Viewing options

Post your comment

Share This Article

Flyer image
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh